MRK Merck Earnings and EPS analysis

EPS in 2026 (TTM): $1.27

Last Report Period Date: Jun 30, 2026

Currently, MRK's 12-month EPS stands at $1.27, according to the most recent financial reports. Merck's earnings per share in 2025 was reported at $7.3, marking a rise from $6.76 in 2024. MRK recorded an EPS of -$0.54 for the quarterly period ending on Jun 30, 2026.

In 2025, Merck's earnings per share was $7.3, a rise of 8% from $6.76 in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was -$0.54, showing a 130.7% decline compared to the same quarter last year. The trailing twelve months EPS for MRK is $1.27 as of June 2026. Merck's full-year EPS for 2024 was $6.76, a 4,728.6% rise compared to the previous year.

Merck has recorded a decline in earnings per share of 130.7% in the past 12 months (YoY, quarterly). During the past three years, MRK registered an average yearly EPS growth of 8.4%. Merck had an average annual EPS growth of 21.2% in the last five years. Over the last decade, MRK had an average annual earnings per share growth of 16.5%.